Sebi asks Sun Pharma to explain alleged fund diversion of Rs 42,000 crore, says report
Updated : March 06, 2019 08:28 AM IST
The market regulator, in two separate notes dated January 28 and February 18, sought an explanation from Sun Pharma to AML’s detailed operations, along with the companies association with Sun, the report said.
Sun Pharma was also asked to explain the rationale, terms and conditions of the advances given to AML as a promoter stakeholder of the pharma company, the report added.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more